Skip to main content

Eurofins Genomics to Supply Oligonucleotides to Swedish Universities

NEW YORK (GenomeWeb) – Eurofins Genomics today announced it signed a two-year contract to be a preferred supplier of oligonucleotides to Lund University.

Eurofins Genomics becomes one of several preferred suppliers as part of a recently awarded framework contract, it said, adding the contract builds on long-standing relationship between the parties. Eurofins will now offer best oligonucleotide prices to Lund University, Gothenburg University, Linköping University, and Chalmers University of Technology.

"This contract will ensure that the whole scientist community in South Sweden will have access to the Eurofins Genomics' products and services and benefit from our commitment to them," Eurofins Genomics Senior VP Bruno Poddevin said in a statement.

In May the company inked a two-year contract with the UK Shared Business Services to be a preferred supplier of oligonucleotides and DNA sequencing.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.